Evrofarma SA (ATH:EVROF)
Greece
· Delayed Price · Currency is EUR 3.610
-0.070 (-1.90%)
Apr 28, 2026, 5:10 PM EET
Evrofarma Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 49.44 | 45.72 | 48.76 | 45.38 | 36.7 | Upgrade
|
| Revenue Growth (YoY) | 8.14% | -6.24% | 7.45% | 23.66% | 8.23% | Upgrade
|
| Cost of Revenue | 38.19 | 36.49 | 41.7 | 39.59 | 32.86 | Upgrade
|
| Gross Profit | 11.25 | 9.23 | 7.06 | 5.8 | 3.84 | Upgrade
|
| Selling, General & Admin | 6.98 | 6.26 | 4.64 | 4.69 | 4.73 | Upgrade
|
| Other Operating Expenses | -0.95 | -1.11 | -1.24 | -1.15 | -1.12 | Upgrade
|
| Operating Expenses | 6.03 | 5.15 | 3.4 | 3.54 | 3.61 | Upgrade
|
| Operating Income | 5.22 | 4.08 | 3.66 | 2.26 | 0.23 | Upgrade
|
| Interest Expense | -0.7 | -1.19 | -1.32 | -0.84 | -0.78 | Upgrade
|
| Earnings From Equity Investments | - | - | 0.06 | 0.02 | 0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | - | 0 | -0.07 | -0.07 | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | 4.53 | 2.89 | 2.32 | 1.36 | -0.54 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -0 | - | -0.02 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0 | Upgrade
|
| Asset Writedown | - | - | 0.39 | 0.16 | 0.3 | Upgrade
|
| Pretax Income | 4.53 | 2.89 | 2.71 | 1.52 | -0.26 | Upgrade
|
| Income Tax Expense | 1 | 0.61 | 0.51 | 0.1 | 0.1 | Upgrade
|
| Net Income | 3.53 | 2.28 | 2.2 | 1.42 | -0.36 | Upgrade
|
| Net Income to Common | 3.53 | 2.28 | 2.2 | 1.42 | -0.36 | Upgrade
|
| Net Income Growth | 54.65% | 3.54% | 55.18% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 14 | - | 14 | 14 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 14 | - | 14 | 14 | 14 | Upgrade
|
| Shares Change (YoY) | - | - | 0.05% | -0.02% | - | Upgrade
|
| EPS (Basic) | 0.26 | - | 0.16 | 0.10 | -0.03 | Upgrade
|
| EPS (Diluted) | 0.26 | - | 0.16 | 0.10 | -0.03 | Upgrade
|
| EPS Growth | - | - | 55.11% | - | - | Upgrade
|
| Free Cash Flow | -0.51 | 4.13 | 0.53 | 0.6 | -4.15 | Upgrade
|
| Free Cash Flow Per Share | -0.04 | - | 0.04 | 0.04 | -0.30 | Upgrade
|
| Dividend Per Share | - | - | 0.050 | - | - | Upgrade
|
| Gross Margin | 22.76% | 20.20% | 14.48% | 12.77% | 10.46% | Upgrade
|
| Operating Margin | 10.56% | 8.92% | 7.50% | 4.97% | 0.63% | Upgrade
|
| Profit Margin | 7.13% | 4.99% | 4.52% | 3.13% | -0.97% | Upgrade
|
| Free Cash Flow Margin | -1.03% | 9.03% | 1.09% | 1.32% | -11.31% | Upgrade
|
| EBITDA | 7.17 | 5.85 | 5.31 | 3.75 | 1.63 | Upgrade
|
| EBITDA Margin | 14.51% | 12.79% | 10.89% | 8.26% | 4.45% | Upgrade
|
| D&A For EBITDA | 1.95 | 1.77 | 1.66 | 1.49 | 1.4 | Upgrade
|
| EBIT | 5.22 | 4.08 | 3.66 | 2.26 | 0.23 | Upgrade
|
| EBIT Margin | 10.56% | 8.92% | 7.50% | 4.97% | 0.63% | Upgrade
|
| Effective Tax Rate | 22.10% | 21.05% | 18.66% | 6.77% | - | Upgrade
|
| Advertising Expenses | - | - | 0.17 | 0.16 | 0.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.